Cannabis Hyperemesis Syndrome Treatment in the Emergency Department
For acute CHS management in the ED, use topical capsaicin (0.1% cream) combined with haloperidol as first-line therapy, while avoiding opioids entirely due to worsening of nausea and high addiction risk. 1
Immediate ED Priorities
Before treating for CHS, you must first rule out life-threatening conditions including acute abdomen, bowel obstruction, mesenteric ischemia, pancreatitis, and myocardial infarction 1. This is critical because the ED approach differs fundamentally from outpatient management—you're not just treating vomiting, you're ensuring nothing surgical or immediately life-threatening is being missed.
First-Line Pharmacologic Treatment
The 2024 AGA guideline provides clear direction based on available evidence from case series and small clinical trials 1:
Primary Agents:
- Topical capsaicin (0.1% cream): Works by activating transient receptor potential vanilloid type 1 receptors, directly counteracting the pathophysiology of CHS 1
- Haloperidol: Dopamine antagonist with proven efficacy in CHS 1, 2
- Droperidol: Alternative dopamine antagonist 3
Secondary Options:
Critical Medication to AVOID
Never use opioids for CHS—they worsen nausea and carry high addiction risk 1. Similarly, benzodiazepines should not be first-line therapy 3.
Practical Implementation
Recent pediatric data shows that after implementing a standardized CHS algorithm, capsaicin use increased from 2.7% to 22.2% and metoclopramide from 6.8% to 42.6%, while haloperidol dosing decreased from 2.7 mg to 1.0 mg 4. This suggests lower haloperidol doses may be effective when combined with other agents.
The RCEM guideline specifically recommends both haloperidol and capsaicin as treatment options based on best available evidence 2.
Diagnostic Clues to Confirm CHS
Look for this specific pattern 1:
- Cannabis use: More than 4 times per week for over 1 year before symptom onset
- Stereotypical episodic vomiting: 3+ times annually
- Hot water bathing behavior: Reported in 71% of CHS cases (though not pathognomonic)
- Demographics: Typically age 30, male predominance (69%)
Disposition Considerations
While conventional management often leads to admission for symptom control, emerging evidence suggests alternative approaches may facilitate ED discharge. One case report demonstrated complete symptom relief with a thoracic erector spinae plane block, avoiding admission 5. However, this remains experimental and requires specialized skills.
Essential Discharge Counseling
The definitive cure is cannabis cessation. Symptoms resolve after 6 months of abstinence or duration equal to 3 typical vomiting cycles 1. Patients frequently remain uncertain about cannabis's role despite diagnosis, often attributing symptoms to food, alcohol, or stress 1. Direct, clear communication about causation is essential.
Common Pitfalls
- Misattributing hot water bathing as pathognomonic: This behavior also occurs in cyclic vomiting syndrome without cannabis 1
- Using conventional antiemetics alone: Ondansetron and metoclopramide have limited efficacy as monotherapy
- Prescribing opioids: This actively worsens the condition
- Missing the diagnosis: CHS prevalence doubled between 2017-2021 in North America, highest in ages 16-34 1